CBR Pharma Insights Market Research Reports

Title published price

Monoclonal Antibodies - Global Trends in the Competitive, Technological and R&D Landscape

By CBR Pharma Insights

Antibodies, otherwise known as immunoglobulins (Ig), are large, Y-shaped glycoproteins produced by immune cells in response to pathogens such as bacteria and viruses. They consist of two large heavy polypeptide chains and two smaller light polypep ...

01-Nov-2017 $2995

A Global Hyperhidrosis Market Landscape Assessment: Trends, Forecasts and Opportunities in a Growing Market

By CBR Pharma Insights

Hyperhidrosis is a chronic disorder of excessive sweating beyond thermoregulatory needs and environmental conditions. It commonly arises in childhood and adolescence, and can affect patients for many years. Most cases of hyperhidrosis involve area ...

19-Oct-2017 $2995

Pharmaceutical Deal Trends 2017 Factbook: Partnerships and Acquisitions Shift Focus Towards Early Stage Development, Emerging Markets, and Biologics

By CBR Pharma Insights

Summary Pharmaceutical market is continuing to see global growth, whereas pharmaceutical and biotechnology companies are facing challenges due to disruptive events in the healthcare market such as increasing costs of produ ...

01-Jul-2017 $2995

Mobile Health (mHealth) Technologies: Global Market Prospects - Featuring Expert Panel Views from Industry Survey 2017

By CBR Pharma Insights

Summary mHealth is often regarded as a branch of eHealth, which has been defined by the European Commission as “The use of modern information and communication technologies to meet needs of citizens, patients, health ...

01-Jun-2017 $2995

Innovation and Clinical Trial Tracking Factbook 2017: An Assessment of the Pharmaceutical Pipeline

By CBR Pharma Insights

Summary Innovation is a crucial element of the pharmaceutical industry. The market is highly research-intensive, being deeply reliant on a high level of R&D investment and a strong product pipeline to maintain growth a ...

01-May-2017 $2995

Pharmaceutical Lifecycle Management Strategies in 2017

By CBR Pharma Insights

Pharmaceutical lifecycle management (LCM) is the process of managing the entire lifecycle of a product including its research, design and manufacture, service and disposal. LCM is a well-established tool to maximize sales throughout the product li ...

01-Apr-2017 $2995

Global Biosimilar Pipeline and Market Prospects: Addressing Production Complexities Through Risk Management and Quality by Design

By CBR Pharma Insights

Summary Government support for biosimilars is increasing in key geographical markets, given the cost saving opportunities that these products represent for national healthcare budgets. A biosimilar is a bio-therapeutic tha ...

01-Mar-2017 $2995

Evolving Pharmaceutical Marketing Strategies: Digital as a Key Component of Multichannel Marketing

By CBR Pharma Insights

Multichannel marketing (MCM) refers to the integration of various marketing channels into an overall synergetic strategy. Utilization of information from all the channels in a feedback loop is termed closed-loop marketing (CLM). While they require ...

24-Feb-2017 $2995

Big Data: Embracing Data to Transform Healthcare and Pharma Commercial Strategy - Featuring Expert Panel Views from Industry Survey 2016

By CBR Pharma Insights

Data generation is growing at an exponential rate, so much so that 90% of the data in the world today was created in the last two years (IBM, 2016a). Big Data refers to any data set that is too large to store, process or analyze using traditional ...

05-Dec-2016 $2995

Global Drug Delivery Technologies - Innovation Driven by Rapidly Expanding Injectables Market and Increasing Usage of Complex Biologics during the Forecast Period

By CBR Pharma Insights

Drug delivery technologies are engineered technologies that deliver drugs to achieve a therapeutic effect. Advances in these technologies usually aim to increase the efficacy of the drug, improve drug absorption and decrease side effects. The glob ...

01-Nov-2016 $2995

Strategic Trends in Private Equity and Venture Capital Funding for Healthcare

By CBR Pharma Insights

Private Equity is a term used to refer to money invested in private companies, and those companies become private through investment. However, in the financial industry the term is used to refer to firms that buy companies through leveraged buyout ...

01-Nov-2016 $2995

The Future of Generic Drugs and Strategies for Commercial Success

By CBR Pharma Insights

Generic drugs are identical or bioequivalent to branded drugs in dosage form, safety, strength, route of administration, quality, performance characteristics and intended use. Although generic drugs are chemically identical to their branded counte ...

01-Sep-2016 $2995

Stem Cell Therapies - Global Trends in the Competitive, Technological and R&D Landscape

By CBR Pharma Insights

GBI Research’s latest report, ""Stem Cell Therapies Global Trends in the Competitive, Technological and R&D Landscape"" provides an in-depth assessment of the current trends in the global stem cell therapy sector with a particular focus ...

01-Jul-2016 $2995

Human Drugs For Veterinary Use - Current Trends and Future Commercial Prospects for Crossover Drugs

By CBR Pharma Insights

GBI Research's latest report, ""Human Drugs For Veterinary Use Current Trends and Future Commercial Prospects for Crossover Drugs"", discusses global commercial trends and prospects for human medicines applied in the veterinary setting, also calle ...

01-Jun-2016 $2995

Innovation Tracking Factbook 2016 - An Assessment of the Pharmaceutical Pipeline

By CBR Pharma Insights

GBI Research’s latest report, ""Innovation Tracking Factbook 2016An Assessment of the Pharmaceutical Pipeline"" is a comprehensive, granular analysis of the 20,756 products currently in the pharmaceutical industry pipeline, from the Discover ...

01-Jun-2016 $2995

Substance Abuse Deterrents and Treatments - An Assessment of the Technological, Competitive and R&D Landscape

By CBR Pharma Insights

GBI Research's latest report, "Substance Abuse Deterrents and Treatments An Assessment of the Technological, Competitive and R&D Landscape", discusses global trends in the substance abuse deterrents and addiction treatments market including th ...

16-Mar-2016 $2995

Telehealth: Global Market Trends, Regulatory Landscape and Operational Strategies

By CBR Pharma Insights

GBI Research's latest report, ""Telehealth: Global Market Trends, Regulatory Landscape and Operational Strategies"", provides key insights into the global telehealth regulatory and market landscape, as well as its main applications in healthcare a ...

01-Mar-2016 $2995

Evolving Market Access Strategies - Pricing and Reimbursement Landscape in Major Developed Pharmaceutical Markets

By CBR Pharma Insights

Summary GBI Research's latest report, "Evolving Market Access Strategies - Pricing and Reimbursement Landscape in Major Developed Pharmaceutical Markets" assesses developments within the key elements of ma ...

01-Jan-2016 $2995

The OTC Drugs Market: Commercial Trends and Rx-to-OTC Switch Prospects

By CBR Pharma Insights

GBI Research’s latest report, ""The OTC Drugs Market: Commercial Trends and Rx-to-OTC Switch Prospects"" discusses trends in the over-the-counter (OTC) pharmaceuticals market and the commercial prospects for switching drugs from prescription ...

14-Dec-2015 $2995

Biobanking: Developing Smart, Sustainable and Ethically Compliant Biorepositories for the Future

By CBR Pharma Insights

GBI Research’s latest report, ""Biobanking: Developing Smart, Sustainable and Ethically Compliant Biorepositories for the Future"" discusses fundamental concepts in biobanking and recent technology advancements in the field. The report also ...

02-Dec-2015 $2995